Substance Abuse Disorder: Prenatal, Intrapartum and Postpartum Care

Area of Science:

• Obstetrics and Gynecology
• Public Health
• Neonatal Care

Background:

• The opioid crisis is a growing concern, disproportionately affecting childbearing women and their infants in the U.S.
• Substance use disorders in pregnancy are now a mainstream issue in pregnancy management, encompassing prescribed medication use, illicit drug misuse, and opioid agonist treatment.
• Identifying pregnant women with substance use disorders is crucial for resource allocation and comprehensive care planning.

Purpose of the Study:

• To highlight the critical need for clinician education in identifying and managing pregnant women with substance use disorders.
• To emphasize the importance of a multidisciplinary, evidence-based approach across the continuum of prenatal, labor, birth, and postpartum care.
• To underscore key considerations such as risk assessment, medication-assisted treatment, pain management, and maternal-infant bonding.

Main Methods:

• This study is a review and synthesis of current knowledge and clinical considerations regarding opioid use and substance use disorders in pregnancy.
• It emphasizes the role of education and multidisciplinary care strategies.
• Focuses on risk assessment, treatment modalities, pain management, and fostering maternal-infant bonding.

Main Results:

• Substance use disorders in pregnancy present unique challenges impacting maternal and infant outcomes.
• Effective management requires a comprehensive, multidisciplinary approach tailored to each stage of care.
• Medication-assisted treatment and supportive nursing interventions are key to improving outcomes.

Conclusions:

• Educating all clinicians on identifying and caring for pregnant women with substance use disorders is essential.
• A comprehensive, evidence-based plan of care, including risk assessment and appropriate treatment, is critical for positive maternal-infant outcomes.
• Empathetic and unbiased nursing advocacy plays a significant role in improving the care and outcomes for mothers and infants affected by substance use disorders.